Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 Patient being positioned for MR study of the head and abdomen. — Image by Ptrump16. CC BY-SA 4.0 The ...

HeartLung.AI will be the only company at ESC Congress 2026 presenting this high number of accepted scientific studies. The achievement reflects the strength of the company’s research program and the ...

Findings from a new study have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart ...

Bedside cardiac assessment (BCA) involves gathering a patient's medical history, performing a physical examination, and determining the need for diagnostic testing. Physicians integrate this ...

LOS ANGELES--(BUSINESS WIRE)--Sensydia, a medical technology company pioneering non-invasive cardiac assessment, today announced that the first patient has been enrolled in its multi-center pivotal ...

A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) ...

Findings from a study supported in part by the National Institutes of Health (NIH) have identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM), a heart condition with a ...

Completion of this 50-subject study is a key milestone on the path to delivering the first device for non-invasive and accurate measurement of pulmonary pressure. LOS ANGELES--(BUSINESS ...

Sensydia Corp. reeled in $8 million in a financing round to advance its noninvasive Cardiac Performance System (CPS) platform, which uses heart sound analysis to enable earlier detection and better ...

Schizophrenia was associated with cardiac electrical instability, suggesting arrhythmic vulnerability was an intrinsic ...